# Covista Inc.: overview

CVSA · NYSE · CIK 730464 · [Other](/sectors/other.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cvsa.md) · [Financials](/companies/cvsa/financials.md) · [Filings](/companies/cvsa/filings.md) · [Insiders](/companies/cvsa/insiders.md)

Latest reported revenue: [$511.5m](/filings/0001104659-26-120213.md) for Q1 FY2027, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-120213).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [448](/filings/0001104659-26-007415.md) | [466](/filings/0001104659-26-057163.md) | [457 d](/filings/0001104659-26-092044.md) | [462](/filings/0001104659-26-120213.md) | [503](/filings/0001104659-26-007415.md) | [487](/filings/0001104659-26-057163.md) | [501 d](/filings/0001104659-26-092044.md) | [512](/filings/0001104659-26-120213.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [23.2%](/filings/0001104659-26-007415.md) | [19.4%](/filings/0001104659-26-057163.md) | [16.8% d](/filings/0001104659-26-092044.md) | [18.5%](/filings/0001104659-26-120213.md) | [22.1%](/filings/0001104659-26-007415.md) | [18.8%](/filings/0001104659-26-057163.md) | [19.0% d](/filings/0001104659-26-092044.md) | [19.2%](/filings/0001104659-26-120213.md) |
| Net margin | % | [16.9%](/filings/0001104659-26-007415.md) | [13.1%](/filings/0001104659-26-057163.md) | [11.9% d](/filings/0001104659-26-092044.md) | [13.4%](/filings/0001104659-26-120213.md) | [15.2%](/filings/0001104659-26-007415.md) | [8.5%](/filings/0001104659-26-057163.md) | [14.3% d](/filings/0001104659-26-092044.md) | [13.2%](/filings/0001104659-26-120213.md) |
| Diluted EPS | $ per share | [1.98](/filings/0001104659-26-007415.md) | [1.59](/filings/0001104659-26-057163.md) | not reported | [1.67](/filings/0001104659-26-120213.md) | [2.11](/filings/0001104659-26-007415.md) | [1.20](/filings/0001104659-26-057163.md) | not reported | [1.95](/filings/0001104659-26-120213.md) |
| Free cash flow | $m | [(29.7) d](/filings/0001104659-26-007415.md) | [198 d](/filings/0001104659-26-057163.md) | [40.7 d](/filings/0001104659-26-092044.md) | [115](/filings/0001104659-26-120213.md) | [15.1 d](/filings/0001104659-26-007415.md) | [166 d](/filings/0001104659-26-057163.md) | [97.1 d](/filings/0001104659-26-092044.md) | [76.4](/filings/0001104659-26-120213.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,382](/filings/0001558370-24-011099.md) | [1,451](/filings/0001558370-25-010780.md) | [1,585](/filings/0001104659-26-092044.md) | [1,788](/filings/0001104659-26-092044.md) | [1,954](/filings/0001104659-26-092044.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.6%](/filings/0001558370-24-011099.md) | [11.6%](/filings/0001558370-25-010780.md) | [13.7%](/filings/0001104659-26-092044.md) | [19.1%](/filings/0001104659-26-092044.md) | [19.6%](/filings/0001104659-26-092044.md) |
| Net margin | % | [22.5%](/filings/0001558370-24-011099.md) | [6.4%](/filings/0001558370-25-010780.md) | [8.6%](/filings/0001104659-26-092044.md) | [13.3%](/filings/0001104659-26-092044.md) | [12.9%](/filings/0001104659-26-092044.md) |
| Diluted EPS | $ per share | [6.43](/filings/0001558370-24-011099.md) | [2.05](/filings/0001558370-25-010780.md) | [3.39](/filings/0001104659-26-092044.md) | [6.18](/filings/0001104659-26-092044.md) | [7.04](/filings/0001104659-26-092044.md) |
| Free cash flow | $m | [(20.5)](/filings/0001558370-24-011099.md) | [166](/filings/0001558370-25-010780.md) | [247](/filings/0001104659-26-092044.md) | [288](/filings/0001104659-26-092044.md) | [393](/filings/0001104659-26-092044.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cvsa/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $683.2m | 5,480,326 |  | Added +250,818 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $401.2m | 3,218,203 |  | Added +563,959 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $297.6m | 2,386,958 |  | Reduced −34,648 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $222.2m | 1,782,750 |  | Added +9,186 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $220.9m | 1,771,844 |  | Reduced −159,440 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $183.7m | 1,473,948 |  | Reduced −16,588 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $173.2m | 1,389,477 |  | Added +40,139 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $132.6m | 1,063,643 |  | Added +34,280 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $111.5m | 894,257 |  | Added +40,248 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $100.0m | 802,055 |  | Reduced −14,243 |

## Recent filings

[All 1,938 filings](/companies/cvsa/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:20 ET | [10-Q](/filings/0001104659-26-120213.md) | Quarterly report, period 2026-09-30 | 0001104659-26-120213 |
| 2026-10-29 | 16:16 ET | [8-K](/filings/0000730464-26-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000730464-26-000062 |
| 2026-10-02 | 16:30 ET | [DEF 14A](/filings/0001104659-26-113316.md) | Proxy statement, period 2026-11-11 | 0001104659-26-113316 |
| 2026-09-23 | 16:15 ET | [8-K](/filings/0000730464-26-000055.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000730464-26-000055 |
| 2026-08-06 | 16:21 ET | [10-K](/filings/0001104659-26-092044.md) | Annual report, period 2026-06-30 | 0001104659-26-092044 |
| 2026-08-06 | 16:19 ET | [8-K](/filings/0000730464-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000730464-26-000037 |
| 2026-07-28 | 16:15 ET | [8-K](/filings/0001104659-26-087540.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-087540 |
| 2026-05-07 | 16:18 ET | [10-Q](/filings/0001104659-26-057163.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057163 |
| 2026-05-07 | 16:10 ET | [8-K](/filings/0000730464-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000730464-26-000021 |
| 2026-04-09 | 08:01 ET | [8-K](/filings/0000730464-26-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000730464-26-000015 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001104659-26-092044.md), filed Aug 6, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/f8382c60-1dc4-493a-bde6-d2b2f808ba75)

## About the filer

- CIK: 730464
- Tickers: CVSA
- Exchange: NYSE
- SIC code: 8200 Services-Educational Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:23 ET. No prices; not investment advice.